DD299155A5 - Pharmazeutische zubereitungen - Google Patents

Pharmazeutische zubereitungen Download PDF

Info

Publication number
DD299155A5
DD299155A5 DD90343663A DD34366390A DD299155A5 DD 299155 A5 DD299155 A5 DD 299155A5 DD 90343663 A DD90343663 A DD 90343663A DD 34366390 A DD34366390 A DD 34366390A DD 299155 A5 DD299155 A5 DD 299155A5
Authority
DD
German Democratic Republic
Prior art keywords
human
amino acids
tpa
acid sequence
amino acid
Prior art date
Application number
DD90343663A
Other languages
German (de)
English (en)
Inventor
Jutta Heim
Fredericus A M Asselbergs
Rolf Buergi
Original Assignee
����`��@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`��@���k�� filed Critical ����`��@���k��
Publication of DD299155A5 publication Critical patent/DD299155A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DD90343663A 1989-09-01 1990-08-27 Pharmazeutische zubereitungen DD299155A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898919803A GB8919803D0 (en) 1989-09-01 1989-09-01 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DD299155A5 true DD299155A5 (de) 1992-04-02

Family

ID=10662394

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90343663A DD299155A5 (de) 1989-09-01 1990-08-27 Pharmazeutische zubereitungen

Country Status (17)

Country Link
US (1) US5409700A (ko)
EP (1) EP0421918B1 (ko)
JP (1) JP2904893B2 (ko)
KR (1) KR910005882A (ko)
AT (1) ATE94407T1 (ko)
AU (1) AU627927B2 (ko)
CA (1) CA2024309C (ko)
DD (1) DD299155A5 (ko)
DE (1) DE69003342T2 (ko)
DK (1) DK0421918T3 (ko)
ES (1) ES2058871T3 (ko)
GB (1) GB8919803D0 (ko)
IE (1) IE63523B1 (ko)
IL (1) IL95525A (ko)
NZ (1) NZ235107A (ko)
PT (1) PT95159B (ko)
ZA (1) ZA906957B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994309A (en) * 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
AU781023B2 (en) 1999-11-04 2005-04-28 Genentech Inc. Reversed-phase HPLC assay for plasminogen activators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8503097A (nl) * 1985-11-11 1987-06-01 Leuven Res & Dev Vzw Geneesmiddel met thrombolytische werking.
NL8601240A (nl) * 1986-05-15 1987-12-01 Leuven Res & Dev Vzw Plasminogeenactivator en trombolytisch geneesmiddel.
FI100106B (fi) * 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
SE462829B (sv) * 1989-01-10 1990-09-10 Kabigen Ab Trombolytiskt aktiva kompositioner innehaallande en modifierad plasminogenaktivator av vaevnadstyp samt en normal human t-pa, streptokinas eller humant urokinas

Also Published As

Publication number Publication date
IL95525A0 (en) 1991-06-30
GB8919803D0 (en) 1989-10-18
IL95525A (en) 1995-03-30
DE69003342T2 (de) 1994-02-24
DE69003342D1 (de) 1993-10-21
AU627927B2 (en) 1992-09-03
JPH03130231A (ja) 1991-06-04
DK0421918T3 (da) 1993-11-15
IE903179A1 (en) 1991-03-13
ZA906957B (en) 1991-06-26
EP0421918B1 (en) 1993-09-15
KR910005882A (ko) 1991-04-27
JP2904893B2 (ja) 1999-06-14
PT95159B (pt) 1997-08-29
US5409700A (en) 1995-04-25
ES2058871T3 (es) 1994-11-01
PT95159A (pt) 1991-05-22
ATE94407T1 (de) 1993-10-15
EP0421918A1 (en) 1991-04-10
AU6205390A (en) 1991-03-07
IE63523B1 (en) 1995-05-03
CA2024309A1 (en) 1991-03-02
NZ235107A (en) 1992-07-28
CA2024309C (en) 2003-05-27

Similar Documents

Publication Publication Date Title
DE69131292T2 (de) Antikoagulierende proteine
DE3687584T3 (de) Vektoren und Verfahren zur Expression einer die Aktivität des menschlichen Proteins-C enthaltenden Substanz.
EP0382174B1 (de) Gewebs-Plasminogenaktivator-Derivat
DE69015182T2 (de) Thrombus-gerichtete komplexe, die aus plasminogenaktivator und fibrinfragmenten zusammengesetzt sind.
DE3689943T2 (de) Degradierte Spezies eines Gewebeplasminogenaktivators, pharmazeutische Zubereitung und Verfahren zur Herstellung derselben.
DE68923741T2 (de) Fledermausspeichel-Plasminogenaktivatoren.
DE68916532T2 (de) Varianten von menschlichem gewebeplasminogenaktivator sowie verfahren zu deren herstellung.
DE3851259T2 (de) Mutierter t-PA mit Kringle-Ersatz.
DE3876348T2 (de) Thrombolytisches agens.
US4996050A (en) Fibrinolytic activity enhancer
DE68918279T2 (de) Plasminogenaktivator-varianten und verfahren zu ihrer herstellung.
EP0669394B1 (de) Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung
DD299155A5 (de) Pharmazeutische zubereitungen
DE3886755T2 (de) Verfahren zur behandlung von gefässkrankheiten.
AT402263B (de) Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
DE3780357T2 (de) Plasminogen-aktivator und thrombolytische zusammensetzung.
DE3855874T2 (de) Neue variante von menschlichem gewebeplasminogenaktivator
EP0714982A2 (de) Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
EP0769050A1 (de) Nicht-glykosylierte plasminogenaktivator-derivate und ihre verwendung bei erhöhtem blutungsrisiko
DE3854195T2 (de) Polypeptid-verbindungen.
DE4440892A1 (de) Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
WO1998005762A1 (de) Thrombinaktivierbarer plasminogenaktivator
EP0400545B1 (de) Gewebs-Plasminogen-Aktivator-Derivat
DE4443273A1 (de) Verwendung der Proteasedomäne von humanem Plasminogenaktivator zur Behandlung von thromboembolischen Erkrankungen
WO1999009184A1 (de) Plasminogenaktivator mit verbesserter zymogenität und verminderter fibrinbindung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee